The article highlights ResMed's exceptional performance over the last 10 years, with an annualized return of 15.88%, which is likely to instill confidence in current and potential investors about the company's growth trajectory and financial health. This positive long-term performance could lead to increased investor interest and potentially drive the stock price up in the short term.